Global Insulin Syringes Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate glucose metabolism. An insulin syringe aids in delivering insulin to diabetic patients in required doses. The rise in prevalence of diabetes and surge in the geriatric population has led to the adoption of Insulin Syringes across the forecast period. For Instance: as per the WHO in 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes and in 2019, about 462 million individuals were affected by type-2 diabetes, corresponding to 6.28% of the world’s population. Also, with the high growth potential in developing countries, the adoption & demand for Insulin Syringes is likely to increase the market growth during the forecast period. However, high price of insulin impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Insulin Syringes Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the favorable government policies related to insulin syringes. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as rising population, rising incidences of injuries and improving healthcare infrastructure would create lucrative growth prospects for the Insulin Syringes market across Asia-Pacific region.

Major market players included in this report are:
Hindustan syringe and medical device Ltd.
Novo Nordisk A/S
Biocon Ltd
Abbott Laboratories
Terumo Corporation
Cardinal Health Inc
Beckton and Dickinson Company
Eli Lilly and Company
Nipro Medical Corporation
Medline Industries

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By End-Use:
Hospitals & Clinics
Homecare Settings
Others
By Diseases:
Type 1 Diabetes
Type 2 Diabetes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Insulin Syringes Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors